Biotechnology Value Fund Ups Its KYMR Stake to 10%

JC Parets
January 10, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a 13G filing by Biotechnology Value Fund.

The investment partnership increased its stake in Kymera Therapeutics Inc $KYMR from 8.45% to 10%.

In another 13G, Millennium Management LLC revealed an initial passive stake of 6.20% in Mobileye Global Inc $MBLY.

Here’s The Hot Corner, with data through January 9, 2024:

Over in Washington, there was some activity from Rep. Josh Gottheimer of New Jersey, who revealed a purchase between $15,000 and $50,000 in Northrop Grumman Corporation $NOC.

In the options market, there was bullish flow in Heron Therapeutics Inc $HRTX, Canada Goose Holdings Inc $GOOS, and Celsius Holdings Inc $CELH.

Stay tuned. We'll be back on Thursday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under